DK0428437T3 - 1,2-benzisoxazolderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem - Google Patents

1,2-benzisoxazolderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem

Info

Publication number
DK0428437T3
DK0428437T3 DK90403145.7T DK90403145T DK0428437T3 DK 0428437 T3 DK0428437 T3 DK 0428437T3 DK 90403145 T DK90403145 T DK 90403145T DK 0428437 T3 DK0428437 T3 DK 0428437T3
Authority
DK
Denmark
Prior art keywords
radical
formula
image
hydrogen atom
represent
Prior art date
Application number
DK90403145.7T
Other languages
Danish (da)
English (en)
Inventor
Jean Louis Peglion
Francis Colpaert
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Application granted granted Critical
Publication of DK0428437T3 publication Critical patent/DK0428437T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK90403145.7T 1989-11-07 1990-11-07 1,2-benzisoxazolderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem DK0428437T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8914571A FR2654104B1 (fr) 1989-11-07 1989-11-07 Nouveaux derives du 1,2-benzisoxazole, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.

Publications (1)

Publication Number Publication Date
DK0428437T3 true DK0428437T3 (da) 1995-01-02

Family

ID=9387148

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90403145.7T DK0428437T3 (da) 1989-11-07 1990-11-07 1,2-benzisoxazolderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem

Country Status (15)

Country Link
US (2) US5100902A (de)
EP (1) EP0428437B1 (de)
JP (1) JPH0692403B2 (de)
AT (1) ATE110075T1 (de)
AU (1) AU631466B2 (de)
CA (1) CA2029372C (de)
DE (1) DE69011628T2 (de)
DK (1) DK0428437T3 (de)
ES (1) ES2062458T3 (de)
FR (1) FR2654104B1 (de)
IE (1) IE65004B1 (de)
NZ (1) NZ235892A (de)
OA (1) OA09468A (de)
PT (1) PT95808B (de)
ZA (1) ZA908884B (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776963A (en) * 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
ES2188584T3 (es) * 1991-03-28 2003-07-01 Eisai Co Ltd Derivados heterociclicos de amina.
US5750542A (en) * 1993-09-28 1998-05-12 Pfizer Benzisoxazole and benzisothizole derivatives as cholinesterase inhibitors
EP0602242A4 (en) * 1991-08-22 1994-06-29 Yoshitomi Pharmaceutical Benzisoxazole compound and use thereof.
WO1993010742A2 (en) * 1991-11-27 1993-06-10 Novo Nordisk A/S Chemical compounds, their preparation and use
US5378714A (en) * 1991-11-27 1995-01-03 Novo Nordisk A/S Antipsychotic piperidine derivatives
FR2694005B1 (fr) * 1992-07-21 1994-08-26 Adir Nouvelles aminoalkylchromones, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
DE69332691T2 (de) * 1992-11-23 2003-12-18 Aventis Pharma Inc Substituierte 3-(aminoalkylamino)-1,2-benzisoxazole und verwandte verbindungen
US5494908A (en) * 1992-11-23 1996-02-27 Hoechst-Roussel Pharmaceutical Incorporated Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds
DK60593D0 (da) * 1993-05-26 1993-05-26 Novo Nordisk As Kemiske forbindelser, deres fremstilling og anvendelse
DK60793D0 (da) * 1993-05-26 1993-05-26 Novo Nordisk As Kemiske forbindelser, deres fremstilling og anvendelse
CA2180841C (en) * 1994-01-10 2007-03-27 Sasson Cohen 1-aminoindan derivatives and compositions thereof
US5914349A (en) 1994-01-10 1999-06-22 Teva Pharmaceutical Industries, Ltd. Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
US6743808B1 (en) 1994-06-08 2004-06-01 H. Lundbeck A/S 4-aryl-1-(indanmethyl, dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl) tetrahydropyridines or piperazines
IL114026A (en) 1994-06-08 1999-06-20 Lundbeck & Co As H 4-aryl-1-(indanmethyl dihydrobenzofuranmethyl or dihydrobenzo thiophenemethyl) piperidines tetrahydropyridines or piperazines and pharmaceutical compositions containing them
ES2101646B1 (es) * 1995-04-12 1998-04-01 Ferrer Int Nuevo compuesto derivado del cromeno.
IL117646A (en) * 1995-04-12 2000-06-01 Ferrer Int 7-¬3-¬4-(6-fluoro-1,2-benzisoxazole-3-YL)piperidin-1-YL¾propoxy¾3-alkyl-chromen-4-ones their preparation their uses and pharmaceutical compositions comprising them
FR2735129B1 (fr) * 1995-06-07 1997-07-11 Adir Nouveaux derives de l'indole, de l'indazole et du benzisoxazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DE69738275T2 (de) 1996-12-18 2008-08-28 Teva Pharmaceutical Industries Ltd. Aminoindanderivate
ZA9711376B (en) 1996-12-20 1998-07-21 Lundbeck & Co As H Indole or dihydroindole derivatives
ES2144355B1 (es) * 1997-12-30 2001-01-01 Ferrer Int Compuestos derivados del cromeno.
US6737547B1 (en) 1998-12-31 2004-05-18 Teva Pharmaceutical Industries, Ltd. Compositions containing and methods of using N-acyl-1H-aminoindenes
WO2001042244A1 (fr) * 1999-12-08 2001-06-14 Grelan Pharmaceutical Co., Ltd. Nouveaux derives 1,8-naphtyridin-2(1h)-one
EP1256575B1 (de) * 2000-02-18 2005-08-17 Meiji Seika Kaisha Ltd. Phenoxyalkylaminderivate als agonisten des opioid-delta rezeptors
JP3772204B2 (ja) * 2000-06-05 2006-05-10 独立行政法人産業技術総合研究所 糖鎖誘導体及びその製造方法
GB0102841D0 (en) * 2001-02-05 2001-03-21 Novartis Ag Organic compounds
US7355042B2 (en) * 2001-10-16 2008-04-08 Hypnion, Inc. Treatment of CNS disorders using CNS target modulators
US20040010038A1 (en) * 2002-02-27 2004-01-15 Eran Blaugrund Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective MAO inhibitors
WO2004009591A1 (en) * 2002-07-22 2004-01-29 Aurobindo Pharma Ltd. A process for the preparation of antipsychotic risperidone
JP2007513197A (ja) * 2003-12-08 2007-05-24 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー 統合失調症の治療のための複素環式置換インダン誘導体および関連化合物
ES2523459T3 (es) * 2005-02-25 2014-11-26 Raqualia Pharma Inc Derivados de benzisoxazol
DE602006012650D1 (de) 2005-04-26 2010-04-15 Hypnion Inc Benzisoxazolpiperidinverbindungen und verfahren zu deren anwendung
DE102005026194A1 (de) * 2005-06-06 2006-12-07 Grünenthal GmbH Substituierte N-Benzo[d]isoxazol-3-yl-amin-Derivate und deren Verwendung zur Herstellung von Arzneimitteln
BRPI0620659A2 (pt) * 2005-12-09 2017-10-31 Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd método para a prevenção do aparecimento de sintomas de uma doença neurodegenerativa em um indivíduo predisposto à doença neurodegenerativa, método de redução de stress oxidante no cérebro de um indivíduo afligido com stress oxidante, método de tratamento de um indivíduo afligido com a degeneração cognitiva suave e composição farmacêutica
TW200744576A (en) * 2006-02-24 2007-12-16 Teva Pharma Propargylated aminoindans, processes for preparation, and uses thereof
JPWO2007126041A1 (ja) 2006-04-28 2009-09-10 エーザイ・アール・アンド・ディー・マネジメント株式会社 ベンゾイソオキサゾール化合物
SI2275423T1 (sl) 2009-07-13 2012-06-29 Krka D.D., Novo Mesto Postopek za sintezo paliperidona
WO2012063269A2 (en) 2010-11-12 2012-05-18 Cadila Healthcare Limited Process for preparing iloperidone
JP2016000697A (ja) * 2012-10-02 2016-01-07 大日本住友製薬株式会社 ピリミジン誘導体
CN109641822B (zh) * 2016-08-12 2022-03-11 拜耳作物科学股份公司 制备取代苯乙烯衍生物的方法
CN115057809B (zh) * 2022-07-15 2024-02-13 扬州市普林斯医药科技有限公司 一种4-(2,4-二氟苯甲酰基)-哌啶的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4355037A (en) * 1981-11-12 1982-10-19 Hoechst-Roussel Pharmaceuticals 3-(4-Piperidyl)-1,2-benzisoxales
US4352811A (en) * 1981-11-12 1982-10-05 Hoechst-Roussel Pharmaceuticals Inc. 3-(1-Substituted-4-piperidyl)-1,2-benzisoxazoles
US4472193A (en) * 1982-07-06 1984-09-18 The Dow Chemical Company Naphthyridinyloxy(or thio)phenoxy propanoic acids, derivatives thereof and methods of herbicidal use
US4528376A (en) * 1982-08-11 1985-07-09 Hoechst-Roussel Pharmaceuticals Inc. 3-(4-Piperidyl)-1,2-benzisoxazoles
AU5529286A (en) * 1985-03-26 1986-10-02 Hayes, B.L. Shock absorbent moving platform
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
JPH01199967A (ja) * 1987-10-26 1989-08-11 Sumitomo Pharmaceut Co Ltd 新規なイミド誘導体
AU6960391A (en) * 1989-12-04 1991-06-26 Schering Corporation Heterocyclic substituted naphthyridinones and methods and compositions employing them

Also Published As

Publication number Publication date
FR2654104B1 (fr) 1992-01-03
US5134147A (en) 1992-07-28
FR2654104A1 (fr) 1991-05-10
CA2029372A1 (fr) 1991-05-08
JPH03188077A (ja) 1991-08-16
DE69011628T2 (de) 1995-03-30
ATE110075T1 (de) 1994-09-15
IE903992A1 (en) 1991-05-08
NZ235892A (en) 1992-08-26
IE65004B1 (en) 1995-10-04
CA2029372C (fr) 1998-01-06
EP0428437B1 (de) 1994-08-17
PT95808B (pt) 1997-11-28
ES2062458T3 (es) 1994-12-16
ZA908884B (en) 1991-08-28
EP0428437A1 (de) 1991-05-22
DE69011628D1 (de) 1994-09-22
PT95808A (pt) 1991-09-13
AU6581990A (en) 1991-05-16
OA09468A (fr) 1992-11-15
US5100902A (en) 1992-03-31
JPH0692403B2 (ja) 1994-11-16
AU631466B2 (en) 1992-11-26

Similar Documents

Publication Publication Date Title
DK0428437T3 (da) 1,2-benzisoxazolderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
ES2083569T3 (es) Nuevos derivados de ariletenileno y procedimiento para su preparacion.
DK0562956T3 (da) Hidtil ukendte naphthylalkylaminer, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
DK1546134T3 (da) Piperazinsubstituerede arylbenzodiazepiner
ATE266664T1 (de) Pyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
YU47002B (sh) N-imidazolini i n-imidazolilmetilni derivati supstituisanih bicikličnih jedinjenja i postupak za njihovo dobijanje
DK0379412T3 (da) Derivater af 1,8-benzonaphthyridin, fremstilling af disse forbindelser og midler, som indeholder forbindelserne
ES2052181T3 (es) Derivados de 2-oxo-1-oxa-8-azaespiro(4,5)decano, procesos para su preparacion y composiciones farmaceuticas de los mismos.
SE9001269L (sv) 2-substituerade n,n'-ditrimetoxbensoylpiperaziner, en framstaellningsmetod foer dessa samt terapeutiska kompositioner som innehaaller dem
NO171362C (no) Analogifremgangsmaate for fremstilling av nye aralkylaminforbindelser og deres salter
DE69823411D1 (de) 2-Aminoidan Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen
DK0463944T3 (da) Hidtil ukendte acylbenzoxazolinoner, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
DE69702955D1 (de) Bis-Imide Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitung
DK614989D0 (da) Indolderivater, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem
NO903512L (no) Nye 1-oxa-2-oxo-8-azaspiro(4,5)decanderivater, farmasoeytiske preparater som inneholder dem og fremgangsmaate for fremstilling av dem.
ES2054234T3 (es) Un procedimiento para la preparacion de derivados indol.
ES2192827T3 (es) Derivados de 8h-(2,3-b)-pirrolicin-8-ona, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ATE49207T1 (de) 3-iminopyridazinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DK0412015T3 (da) Hidtil ukendte N-(23-vincristinoyl)- og N-(5-noranhydro-23-vinblastinoyl)-1-aminomethylphosphon- syrederivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
ATE218574T1 (de) Bis pyrido(4,3-b)carbazolverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
TH37483A (th) อนุพันธ์ 5-เมโรอิลแนพธาลีน